A New Protocol for Predicting Novel GSK-3β ATP Competitive Inhibitors-Reference-Cited by-同舟云学术

A New Protocol for Predicting Novel GSK-3β ATP Competitive Inhibitors

Published:2011-06-09 Issue:6 Volume:51 Page:1431-1438
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Fang Jiansong¹,Huang Dane¹,Zhao Wenxia¹,Ge Hu¹,Luo Hai-Bin¹,Xu Jun¹

Affiliation:

1. Research Center for Drug Discovery and Institute of Human Virology, School of Pharmaceutical Sciences, Sun Yat-Sen University, 132 East Circle at University City, Guangzhou, China 510006

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci2001154

Reference43 articles.

1. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

2. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

3. Molecular cloning and expression of glycogen synthase kinase-3/factor A.

4. Glycogen Synthase Kinase-3: Properties, Functions, and Regulation

5. Glycogen synthase kinase 3: an emerging therapeutic target

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach;Bioorganic Chemistry;2024-06

2. Developing a straightforward route toward the synthesis of arylaminomaleimides by palladium-catalyzed arylation of one-pot synthesized aminomaleimides;Organic & Biomolecular Chemistry;2024

3. Structure-related relationship: Plant-derived antidiabetic compounds;Studies in Natural Products Chemistry;2023

4. PTML Modeling for Alzheimer’s Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6;Current Topics in Medicinal Chemistry;2020-09-14

5. 3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase;Archives of Pharmacal Research;2020-04-04